1. Home
  2. M vs GRFS Comparison

M vs GRFS Comparison

Compare M & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Macy's Inc

M

Macy's Inc

HOLD

Current Price

$23.81

Market Cap

6.3B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.37

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
M
GRFS
Founded
1830
1940
Country
United States
Spain
Employees
94189
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.2B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
M
GRFS
Price
$23.81
$9.37
Analyst Decision
Hold
Hold
Analyst Count
11
2
Target Price
$19.89
$10.15
AVG Volume (30 Days)
6.1M
449.7K
Earning Date
12-03-2025
07-28-2022
Dividend Yield
3.08%
1.50%
EPS Growth
331.62
N/A
EPS
1.71
0.64
Revenue
$22,712,000,000.00
$8,821,017,248.00
Revenue This Year
N/A
$5.36
Revenue Next Year
N/A
$5.15
P/E Ratio
$13.85
$18.49
Revenue Growth
N/A
7.31
52 Week Low
$9.76
$6.19
52 Week High
$24.41
$11.14

Technical Indicators

Market Signals
Indicator
M
GRFS
Relative Strength Index (RSI) 54.93 59.64
Support Level $22.21 $9.17
Resistance Level $23.85 $9.57
Average True Range (ATR) 0.72 0.19
MACD -0.05 0.03
Stochastic Oscillator 59.55 72.70

Price Performance

Historical Comparison
M
GRFS

About M Macy's Inc

Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: